Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.087 | 0.3 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.3 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |